Skip to main content
  • Prescribing Information
    • Jivi
    • Kovaltry
    • Kogenate
  • Bayer Global

This website is for healthcare professionals only

If you are a healthcare professional, please select your country to visit your local website:

If you are a HCP and would like to visit the global Hemophilia website, please confirm this by pressing the button below.

  • I am an HCP; Visit Global Website

This website contains information based on the Summary of Product Characteristics (SPC), as approved by the European Commission on Jivi (damoctog alfa pegol), Kovaltry (octocog alfa) and Kogenate FS (octocog alfa). It is intended to provide information to an international audience. In countries outside the EU, the local Product Information applies.

Alt Hemophilia Hub
  • Bayer in Hemophilia
  • Products
    • Overview
    • Jivi
      • Why Jivi?
      • The Jivi Experience
      • Bleed Resolution and Major Surgeries
      • The Jivi Molecule
      • Dosing Information
      • Administration and Monitoring
      • Study Designs
    • Kovaltry
      • Efficacy & Safety
        • Factor VIII Threshold
        • Factor VIII Activity
        • PK & Time to Threshold
        • PK Across Age
        • Safety
      • Practical Usage
        • Dosing
        • Vial Adaptor & Sizes
        • Storage
      • The Molecule
    • Kogenate FS/Bayer
  • Tools & Resources
    • Overview
    • Joint Visualiser
    • Download Resource Centre
    • myWAPPS
    • WAPPS Integrated Service
  • Latest in Hemophilia
  • Engagement Programs
  • Bayer in Hemophilia
  • Products
    • Overview
    • Jivi
      • Why Jivi?
      • The Jivi Experience
      • Bleed Resolution and Major Surgeries
      • The Jivi Molecule
      • Dosing Information
      • Administration and Monitoring
      • Study Designs
    • Kovaltry
      • Efficacy & Safety
        • Factor VIII Threshold
        • Factor VIII Activity
        • PK & Time to Threshold
        • PK Across Age
        • Safety
      • Practical Usage
        • Dosing
        • Vial Adaptor & Sizes
        • Storage
      • The Molecule
    • Kogenate FS/Bayer
  • Tools & Resources
    • Overview
    • Joint Visualiser
    • Download Resource Centre
    • myWAPPS
    • WAPPS Integrated Service
  • Latest in Hemophilia
  • Engagement Programs
  • Prescribing Information
    • Jivi
    • Kovaltry
    • Kogenate
  • Bayer Global
  • Country select
    • Gemany
    • Japan
    • United States
  • Prescribing Information
  • Bayer Global
Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Kogenate FS/Bayer

Breadcrumb
  1. Home
  2. Products
  3. Kogenate FS/Bayer

Prescribing information

Kogenate FS/Bayer is indicated for the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency) for adults, adolescents and children of all ages.

 

Prescribing information

Kogenate logo

Recommendations

Discover the Power of Jivi

Kovaltry

Related Topics

Bayer in Hemophilia Tools & Resources Programs for Your Hemophilia Patients

  • General Conditions of Use
  • Imprint
  • Privacy statement
  • Report a Side Effect
  • Jivi Prescribing information
  • Kovaltry Prescribing information
  • Kogenate Prescribing information
  • Contact Us
  • Sitemap
  • Cookies Settings

© 2022 Bayer AG

This website is intended to provide information to an international audience outside the USA and UK
PP-JIV-ALL-0492-2

  • PP-JIV-ALL-0302-1

Last updated: June 2022

hidden link for autofocus
Cookie consent image